Clinical pharmacokinetics of gemifloxacin following single oral dose administration in healthy Chinese male subjects
CAO Guo-ying,ZHANG Jing,YU Ji-cheng,GUO Bei-ning,SHI Yao-guo,Yingyuan Zhang
DOI: https://doi.org/10.16718/j.1009-7708.2009.05.019
2009-01-01
Abstract:Objective To investigate the pharmacokinetics of gemifloxacin in healthy Chinese subjects in order to provide rationale for developing safe and effective clinical dosage regimen in Chinese patients.Methods Twelve subjects were enrolled in an open label,3-period,single oral dose,cross-over pharmacokinetic study. The subjects sequentially took 3 doses of gemifloxacin (160 mg,320 mg and 480 mg) according to the randomization schedule. The concentrations of gemifloxacin in serum and urine were determined by high performance liquid chromatogram (HPLC). The pharmacokinetic parameters were analyzed by Winnonlin software.Results The pharmacokinetic courses following single crossover oral dose of 160 mg,320 mg and 480 mg gemifloxacin were all consistent with the non-compartment model. The means of C max were (0.70±0.19) mg/L,(1.40±0.32) mg/L and (1.84±0.35) mg/L,respectively. The medians of T max were 1 (0.5,2) h,1 (0.5,2) h and 1.25 (1,2) h,respectively. The means of t 1/2 were (7.06±1.22) h,(7.02±0.94) h and (7.28±0.81) h,respectively. The means of AUC 0-24 h were (3.86±0.56) mg·h/L,(7.61±0.93) mg·h/L and (11.47±1.68) mg·h/L,respectively. The means of AUC 0-∞ were (4.01±0.57) mg·h/L,(7.71±0.92) mg·h/L and (11.62±1.72) mg·h/L,respectively. The means of V d were (411.45±77.88) L,(423.47±59.48) L and (439.21±55.55) L,respectively. The means of CL t were (40.71±6.22) L/h,(42.10±5.46) L/h and (42.26±7.14) L/h,respectively. The means of accumulative urinary excretion at 48 hours post dosing were (38.95±6.14)%,(37.84±6.62)% and (35.57±5.07)%,respectively. Conclusions The results indicate that pharmacokinetic courses following single oral dose of 160 mg,320 mg and 480 mg gemifloxacin are linear. The half-life is long. Gemifloxacin is partly excreted from kidney. About 40% of the dosage is recovered in the urine at 48 hours post dosing.